| Ident. | Authors (with country if any) | Title |
|---|
| 000016 |
C. P. Ford [États-Unis] | THE ROLE OF D2-AUTORECEPTORS IN REGULATING DOPAMINE NEURON ACTIVITY AND TRANSMISSION |
| 000033 |
G. Drui [France] ; S. Carnicella [France] ; C. Carcenac [France] ; M. Favier [France] ; A. Bertrand [France] ; S. Boulet [France] ; M. Savasta [France] | Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease |
| 000040 |
M. Morales [États-Unis] ; D. H. Root [États-Unis] | GLUTAMATE NEURONS WITHIN THE MIDBRAIN DOPAMINE REGIONS |
| 000049 |
Omar Ouachikh [France] ; Wisam Dieb [France] ; Franck Durif [France] ; Aziz Hafidi [France] | Anterior ventral tegmental area dopaminergic neurons are not involved in the motivational effects of bromocriptine, pramipexole and cocaine in drug-free rats |
| 000440 |
Fanny Schmiijt [France] ; Gael Le Douaron [France] ; Pierre Champy [France] ; Majid Amar [France] ; Blandine Seon-Meniel [France] ; Rita Raisman-Vozari [France] ; Bruno Figadere [France] | Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons |
| 000482 |
Jérémie Vitte [France] ; Sabine Traver [France] ; André Maues De Paula [France] ; Suzanne Lesage [France] ; Giorgio Rovelli [Suisse] ; Olga Corti [France] ; Charles Duyckaerts [France] ; Alexis Brice [France] | Leucine-Rich Repeat Kinase 2 Is Associated With the Endoplasmic Reticulum in Dopaminergic Neurons and Accumulates in the Core of Lewy Bodies in Parkinson Disease |
| 000496 |
Ouafa Arib [France] ; Pascal Rat [France] ; Robert Molimard [France] ; Abderrahman Chait [Maroc] ; Philippe Faure [France] ; Renaud De Beaurepaire [France] | Electrophysiological characterization of harmane-induced activation of mesolimbic dopamine neurons |
| 000546 |
Faustine Lelan [France] ; Philippe Damier | Les neurones dopaminergiques greffés dans la maladie de parkinson sont-il à leur tour atteints par le processus dégénératif ? |
| 000588 |
Serge Guerreiro [France] ; Aurélie Ponceau [France] ; Damien Toulorge [France] ; Elodie Martin [France] ; Daniel Alvarez-Fischer [France] ; Etienne C. Hirsch [France] ; Patrick P. Michel [France] | Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization |
| 000612 |
Vincent Henry [France] ; Vincent Paille [France] ; Faustine Lelan [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Kinetics of Microglial Activation and Degeneration of Dopamine-Containing Neurons in a Rat Model of Parkinson Disease Induced by 6-Hydroxydopamine |
| 000680 |
Pierre Cesaro [France] | Neuroprotection et maladie de Parkinson |
| 000697 |
Jacques Epelbaum [France] | Foxa2, une nouvelle piste neuro-développementale pour le Parkinson |
| 000723 |
Imane Nafia [France] ; Diane B. Re [France] ; Frédérique Masmejean [France] ; Christophe Melon [France] ; Philippe Kachidian [France] ; Lydia Kerkerian-Le Goff [France] ; André Nieoullon [France] ; Laurence Had-Aissouni [France] | Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction |
| 000728 |
Daniel Hamack [Allemagne] ; Wassilios Meissner [France] ; Julia A. Jira [Allemagne] ; Christine Winter [Allemagne] ; Rudolf Morgenstern [Allemagne] ; Andreas Kupsch [Allemagne] | Placebo-controlled chronic high-frequency stimulation of the subthalamic nucleus preserves dopaminergic nigral neurons in a rat model of progressive Parkinsonism |
| 000742 |
Daniel Alvarez-Fischer [France] ; Serge Guerreiro [France] ; Stephane Hunot [France] ; Francoise Saurini [France] ; Marc Marien [France] ; Pierre Sokoloff [France] ; Etienne C. Hirsch [France] ; Andreas Hartmann [France] ; Patrick P. Michel [France] | Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid |
| 000745 |
Carine Chassain [France] ; Guy Bielicki [France] ; Elodie Durand [France] ; Stéphane Lolignier [France] ; Fatma Essafi [Tunisie] ; Amidou Traore [France] ; Franck Durif [France] | Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse |
| 000748 |
Charlotte Laloux [France] ; Philippe Derambure [France] ; Alexandre Kreisler [France] ; Elise Houdayer [France] ; Servane Brueziere [France] ; Régis Bordet [France] ; Alain Destée [France] ; Christelle Monaca [France] | MPTP-treated mice : long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations |
| 000857 |
Patrick P. Michel [France] ; Daniel Alvarez-Fischer [France] ; Serge Guerreiro [France] ; Audrey Hild [France] ; Andreas Hartmann [France] ; Etienne C. Hirsch [France] | Role of activity-dependent mechanisms in the control of dopaminergic neuron survival |
| 000898 |
N. A. Do Thi [France] ; P. Saillour [France] ; L. Ferrero [France] ; T. Paunio [Finlande] ; J. Mallet [France] | Does neuronal expression of GDNF effectively protect dopaminergic neurons in a rat model of Parkinson's disease? |
| 000B03 |
Sophie Mourlevat [France] ; Thomas Debeir [France] ; Juan E. Ferrario [France] ; Jean Delbe [France] ; Daniele Caruelle [France] ; Olivier Lejeune [France] ; Christel Depienne [France] ; José Courty [France] ; Rita Raisman-Vozari [France] ; Merle Ruberg [France] | Pleiotrophin mediates the neurotrophic effect of cyclic AMP on dopaminergic neurons : Analysis of suppression-subtracted cDNA libraries and confirmation in vitro |
| 000C15 |
Vincent Paille [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease |
| 000C29 |
P. O. Fernagut [France] ; E. Diguet [France] ; B. Bioulac [France] ; F. Tison [France] | MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: eeference to striatonigral degeneration |
| 000C56 |
N. A. Do Thi [France] ; P. Saillour [France] ; L. Ferrero [France] ; I. F. Dedieu [France] ; J. Mallet [France] ; T. Paunio [France, Finlande] | Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease |
| 000C95 |
Ph. Remy [France] ; Z. Malek [France] ; E. Itti [France] | Mise en évidence de la perte des neurones dopaminergiques nigro-striataux par la scintigraphie cérébrale au [123I]-Ioflupane (DatScan®) : Principes et applications : Formation post-universitaire |
| 000D03 |
O. Guillin [France] | Le BDNF contrôle la transmission dopaminergique : implications dans la maladie de Parkinson |
| 000D07 |
Olga Corti [France] ; Alexis Brice [France] | La maladie de Parkinson : que nous apprennent les gènes responsables des formes familiales? |
| 000D11 |
Ph. Remy [France] | L'imagerie fonctionnelle a-t-elle une place en clinique dans la maladie de Parkinson ? |
| 000D38 |
A. Lannuzel [France] ; P. P. Michel [France] ; G. U. Höglinger [France] ; P. Champy [France] ; A. Jousset [France] ; F. Medja [France] ; A. Lombes [France] ; F. Darios [France] ; C. Gleye [France] ; A. Laurens [France] ; R. Hocquemiller [France] ; E. C. Hirsch [France] ; M. Ruberg [France] | The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism |
| 000D48 |
Erwan Bezard [France] ; Christian E. Gross [France] ; Jonathan M. Brotchie [Canada] | Presymptomatic compensation in Parkinson's disease is not dopamine-mediated |
| 000D58 |
Baptiste A. Faucheux [France] ; Marie-Elise Martin [France] ; Carole Beaumont [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease |
| 000D59 |
Stephane Hunot [France] ; E. C. Hirsch [France] | Neuroinflammatory processes in Parkinson's disease. Discussion |
| 000D89 |
Benoit Melchior [France] ; Véronique Nerriere-Daguin [France] ; David-A. Laplaud [France] ; Séverine Remy [France] ; Sandrine Wiertlewski [France] ; Isabelle Neveu [France] ; Philippe Naveilhan [France] ; Susan O. Meakin [Canada] ; Philippe Brachet [France] | Ectopic expression of the TrkA receptor in adult dopaminergic mesencephalic neurons promotes retrograde axonal NGF transport and NGF-dependent neuroprotection |
| 000D99 |
Karine Parain [France] ; Céline Hapdey [France] ; Estelle Rousselet [France] ; Véronique Marchand [France] ; Bernard Dumery [France] ; Etienne C. Hirsch [France] | Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin |
| 000E00 |
Günter U. Höglinger [France, Allemagne] ; Jean Feger [France] ; Annick Prigent [France] ; Patrick P. Michel [France] ; Karine Parain [France] ; Pierre Champy [France] ; Merle Ruberg [France] ; Wolfgang H. Oertel [Allemagne] ; Etienne C. Hirsch [France] | Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats |
| 000E09 |
Carine Cleren [France] ; Bertrand Naudin [France] ; Jean Costentin [France] | Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons |
| 000E14 |
| Parkinson et mouvements anormaux |
| 000E36 |
F. Viallet [France] ; T. Witjas [France] | Neuroplasticité et maladie de Parkinson |
| 000E38 |
Nathalie Lambeng [France] ; Raphaël Hourez [Belgique] ; Sakina Torch [France] ; Jean-Marc Verna [France] ; David Blum [Belgique] | Mort neuronale dans les modèles expérimentaux de la maladie de Parkinson |
| 000E45 |
P.-P. Michel [France] ; E.-C. Hirsch [France] ; Yves Agid [France] | Maladie de Parkinson : mécanismes de la mort cellulaire |
| 000E89 |
Estelle Rousselet [France] ; Jacques Callebert [France] ; Karine Parain [France] ; Chantal Joubert [France] ; Stéphane Hunot [France] ; Andreas Hartmann [France] ; Claude Jacque [France] ; Fernando Perez-Diaz [France] ; Charles Cohen-Salmon [France] ; Jean-Marie Launay [France] ; Etienne C. Hirsch [France] | Role of TNF-α receptors in mice intoxicated with the parkinsonian toxin MPTP |
| 000E93 |
Stéphanie Barc [France] ; Guylène Page [France] ; Laurence Barrier [France] ; Lucette Garreau [France] ; Denis Guilloteau [France] ; Bernard Fauconneau [France] ; Sylvie Chalon [France] | Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat |
| 000E95 |
T. Breidert [France] ; J. Callebert [France] ; M. T. Heneka [Allemagne] ; G. Landreth [États-Unis] ; J. M. Launay [France] ; E. C. Hirsch [France] | Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease |
| 000F12 |
Maria C. Obinu [France] ; Michel Reibaud [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Assunta Imperato [France] | Neuroprotective effect of riluzole in a primate model of Parkinson's disease: Behavioral and histological evidence |
| 000F13 |
Wakako Maruyama [Japon] ; Yukihiro Akao [Japon] ; Maria Chrisina Carrillo [Argentine] ; Ken-Ichi Kitani [Japon] ; Moussa B. H. Youdium [Israël] ; Makoto Naoi [Japon] | Neuroprotection by propargylamines in Parkinson's disease: Suppression of apoptosis and induction of prosurvival genes |
| 000F14 |
Martine Barkats [France] ; Stéphanie Millecamps [France] ; Alicia Bilang-Bleuel [France] ; Jacques Mallet [France] | Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine |
| 000F27 |
Baptiste A. Faucheux [France] ; Marie-Elise Martin [France] ; Carole Beaumont [France] ; Stéphane Hunot [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease |
| 000F36 |
K. L. Double [Australie] ; D. Ben-Shachar [Israël] ; M. B. H. Youdim [Israël] ; L. Zecca [Italie] ; P. Riederer [Allemagne] ; M. Gerlach [Allemagne] | Influence of neuromelanin on oxidative pathways within the human substantia nigra |
| 000F41 |
Sophie Callier [France, Canada] ; Maryvonne Le Saux [France] ; Anne-Marie Lhiaubet [France] ; Thérèse Di Paolo [Canada] ; William Rostene [France] ; Didier Pelaprat [France] | Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurones in primary culture |
| 000F44 |
Aïcha Douhou [France] ; Thomas Debeir [France] ; Mario Gustavo Murer [Argentine] ; Louis Do [France] ; Noëlle Dufour [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Georg Andrees Bohme [France] ; Yves Agid [France] ; Rita Raisman-Vozari [France] | Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice |
| 000F45 |
A. D. Smith [États-Unis] ; M. Amalric [France] ; G. F. Koob [États-Unis] ; M. J. Zigmond [États-Unis] | Effect of bilateral 6-hydroxydopamine lesions of the medial forebrain bundle on reaction time |
| 000F77 |
E. Lehtonen [Belgique] ; F. Bonnaud [France] ; C. Melas [Belgique] ; A. Lubansu [Belgique] ; B. Malgrange [Belgique] ; A. Chtarto [Belgique] ; T. Velu [Belgique] ; J. Brotchi [Belgique] ; M. Levivier [Belgique] ; M. Peschanski [France] ; L. Tenenbaum [Belgique] | AAV2 vectors mediate efficient and sustained transduction of rat embryonic ventral mesencephalon |
| 000F82 |
| EFFETS D'UNE DEPOLARISATION CHRONIQUE SUR LE DEVELOPPEMENT ET LA SURVIE DES NEURONES DOPAMINERGIQUES DU MESENCEPHALE : MODULATION PAR DES ANTAGONISTES DE LA TRANSMISSION GLUTAMATERGIQUE |
| 000F87 |
| Les neurones dopaminergiques : le GDNF et la neurturine comme facteurs de survie la xénotransplantation comme approche restauratrice |
| 001032 |
Oum-Kaltoum Hassani [France] ; Mireille Mouroux [France] ; Georg Andrees Bohme [France] ; Jean-Marie Stutzmann [France] ; Jean Feger [France] | Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain |
| 001043 |
Karine Parain [France] ; Véronique Marchand [France] ; Bernard Dumery [France] ; Etienne Hirsch [France] | Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice |
| 001052 |
Andreas Hartmann [France] ; Patrick P. Michel [France] ; Jean-Denis Troadec [France] ; Annick Mouatt-Prigent [France] ; Baptiste A. Faucheux [France] ; Merle Ruberg [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease? |
| 001069 |
W. Maruyama [Japon] ; A. A. Boulton [Canada] ; B. A. Davis [Canada] ; P. Dostert [France] ; M. Naoi [Japon] | Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells : Suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine |
| 001090 |
Olivier Guillin [France] ; Jorge Diaz [France] ; Patrick Carroll [France] ; Nathalie Griffon [France] ; Jean-Charles Schwartz [France] ; Pierre Sokoloff [France] | BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization |
| 001119 |
J. Mallet [France] | Remplacer les neurones ? : S.O.S. Neurones |
| 001194 |
Etienne C. Hirsch [France] ; Céline Perier [France] ; Gaël Orieux [France] ; Chantal Francois [France] ; Jean Feger [France] ; Jérome Yelnik [France] ; Miquel Vila [France] ; Richard Levy [France] ; Eduardo S. Tolosa [Espagne] ; Concepcio Marin [Espagne] ; M. Trinidad Herrero [Espagne] ; José A. Obeso [Espagne] ; Yves Agid [France] | Metabolic effects of nigrostriatal denervation in basal ganglia |
| 001227 |
Wakako Maruyama [Japon] ; Kumiko Sango [Japon] ; Kinuko Iwasa [Japon] ; Chiyoko Minami [Japon] ; Philippe Dostert [France] ; Masao Kawai [Japon] ; Masataka Moriyasu [Japon] ; Makoto Naoi [Japon] | Dopaminergic neurotoxins, 6,7-dihydroxy-1-(3', 4')-dihydroxybenzyl)-isoquinolines, cause different types of cell death in SH-SY5Y cells : apoptosis was induced by oxidized papaverolines and necrosis by reduced tetrahydropapaverolines |
| 001237 |
A. Nicotra [Italie] ; S. H. Parvez [France] | Cell death induced by MPTP, a substrate for monoamine oxidase B |
| 001241 |
Makoto Naoi [Japon] ; Wakako Maruyama [Japon] ; Yukihito Akao [Japon] ; JIN ZHANG [Japon] ; Hasan Parvez [France] | Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons |
| 001243 |
P. Jenner [Royaume-Uni] ; B.-Y. Zeng [Royaume-Uni] ; L. A. Smith [Royaume-Uni] ; R. K. B. Pearce [Royaume-Uni] ; B. Tel [Royaume-Uni] ; L. Chancharme [France] ; G. Moachon [France] | Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset |
| 001256 |
| Développement des neurones dopaminergiques et environnement matriciel : analyse in vivo et in vitro du rôle des protéoglycannes dans la mise en place des voies mésostriatales chez le rat |
| 001273 |
P. Remy [France] ; P. Hantraye [France] ; Y. Samson [France] | La tomographie par émission de positions, un outil de recherche fondamentale devenu indispensable à la recherche clinique : L'exemple des greffes neuronales dans la maladie de Parkinson |
| 001292 |
V. Ben [France] ; O. Blin [France] ; B. Bruguerolle [France] | Time-dependent striatal dopamine depletion after injection of 6-hydroxydopamine in the rat. Comparison of single bilateral and double bilateral lesions |
| 001294 |
P. Damier [France, États-Unis] ; E. C. Hirsch [France] ; Yves Agid [France] ; A. M. Graybiel [États-Unis] | The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease |
| 001295 |
P. Damier [France, États-Unis] ; E. C. Hirsch [France] ; Yves Agid [France] ; A. M. Graybiel [États-Unis] | The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D28K immunohistochemistry |
| 001332 |
M. G. Murer [Argentine] ; J. Ferrario [Argentine] ; M. Delfino [Argentine] ; G. Dziewczapolski [Argentine] ; O. S. Gershanik [Argentine] ; R. Raisman-Vozari [France] | Increased [125I]sulpiride binding in the subthalamic nucleus of rats with nigrostriatal lesions |
| 001363 |
A. Sanchez-Capelo [France] ; O. Corti [France] ; J. Mallet [France] | Adenovirus-mediated over-expression of TGFβ1 in the striatum decreases dopaminergic cell survival in embryonic nigral grafts |
| 001364 |
P. P. Michel [France] ; M. Marien [France] ; M. Ruberg [France] ; F. Colpaert [France] ; Yves Agid [France] | Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes |
| 001368 |
E. Bezard [France] ; C. E. Gross [France] ; M.-C. Fournier [France] ; S. Dovero [France] ; B. Bloch [France] ; M. Jaber [France] | Absence of MPTP-lnduced neuronal death in mice lacking the dopamine transporter |
| 001395 |
B. A. Faucheux [France] ; E. C. Hirsch [France] | Homéostasie du fer et maladie de Parkinson |
| 001447 |
E. C. Hirsch [France] ; S. Hunot [France] ; P. Damier [France] ; B. Faucheux [France] | Glial cells and inflammation in Parkinson's disease : A role in neurodegeneration? |
| 001458 |
A. Nicole [France] ; D. Santiard-Baron [France] ; I. Ceballos-Picot [France] | Direct evidence for glutathione as mediator of apoptosis in neuronal cells : Dossier "Apoptosis Part II" |
| 001463 |
M. G. Murer [France] ; G. Dziewczapolski [Argentine] ; L. B. Menalled [Argentine] ; M. C. Garcia [Argentine] ; Yves Agid [France] ; O. Gershanik [Argentine] ; R. Raisman-Vozari [France] | Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions |
| 001470 |
| Toxicité du glutamate sur des cultures primaires de neurones mésencéphaliques de la substance noire |
| 001474 |
| CONTRÔLE DE L'EXCITABILITÉ DES NEURONES DOPAMINERGIQUES DE LA SUBSTANCE NOIRE COMPACTE DE RAT PAR LES CATÉCHOLAMINES ET LES NEUROPEPTIDES |
| 001478 |
| Effet de la mutation weaver sur la dégénérescence des neurones dopaminergiques du mésencéphale ventral : analyse de l'expression du transporteur membranaire de la dopamine et d'un canal potassique couplé à une protéine G |
| 001508 |
P. Damier [France] | Lésions neurochimiques et mécanismes de la mort neuronale dans la maladie de Parkinson : Maladie de Parkinson |
| 001521 |
G. Defer [France] | Greffes intrastriatales de neurones embryonnaires dans la maladie de Parkinson : Maladie de Parkinson - 2e partie |
| 001553 |
P. P. Michel [France] ; M. Ruberg [France] ; Yves Agid [France] | Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside |
| 001558 |
E. Bezard [France] ; T. Boraud [France] ; B. Bioulac [France] ; C. E. Gross [France] | Presymptomatic revelation of experimental Parkinsonism |
| 001561 |
E. C. Hirsch [France] ; M. T. Herrero [Espagne] | Neurochemical correlates of parkinsonism: Role of dopaminergic lesions |
| 001568 |
N. B. Mercuri [Italie] ; A. Saiardi [France] ; A. Bonci [Italie] ; R. Picetti [France] ; P. Calabresi [Italie] ; G. Bernardi [Italie] ; E. Borrelli [France] | Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice |
| 001570 |
M. Ruberg [France] ; B. Brugg [France] ; A. Prigent [France] ; E. Hirsch [France] ; A. Brice [France] ; Yves Agid [France] | Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis? |
| 001581 |
E. Bezard [France] ; S. Dovero [France] ; B. Bioulac [France] ; C. Gross [France] | Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice |
| 001595 |
C. Adelbrecht [France] ; M. G. Murer [France] ; I. Lauritzen [France] ; F. Lesage [France] ; M. Ladzunski [France] ; Yves Agid [France] ; R. Raisman-Vozari [France] | An immunocytochemical study of a G-protein-gated inward rectifier K+ channel (GIRK2) in the weaver mouse mesencephalon |
| 001606 |
| Vulnérabilité différentielle des neurones dopaminergiques dans la maladie de parkinson: un rôle du stress oxydatif et de l'environnement glial ? |
| 001640 |
S. Hunot [France] ; F. Boissiere [France] ; B. Faucheux [France] ; B. Brugg [France] ; A. Mouatt-Prigent [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Nitric oxide synthase and neuronal vulnerability in Parkinson's disease |
| 001655 |
C. Adelbrecht [France] ; Yves Agid [France] ; R. Raisman-Vozari [France] | Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area |
| 001657 |
V. Blanchard [France] ; P. Anglade [France] ; G. Dziewczapolski ; M. Savasta [France] ; Yves Agid [France] ; R. Raisman-Vozari [France] | Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra |
| 001658 |
P. Damier [France] ; A. Kastner [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease ? |
| 001664 |
P. P. Michel [France] ; Yves Agid [France] | Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons |
| 001673 |
| Etude de la plasticité des neurones dopaminergiques du mésencéphale ventral dans un modèle expérimental de la phase préclinique de la maladie de Parkinson: adaptations à long terme de la tyrosine hydroxylase et des transporteurs de la dopamine |
| 001674 |
| Analyse moléculaire et cellulaire de la mutation weaver de la souris |
| 001679 |
| Synthèse et marquage au carbone-11 et au fluor-18 d'inhibiteurs de capture de la Dopamine pour une étude du système dopaminergique en Tomographie par Emission de Positons |
| 001694 |
J. Costentin [France] | La maladie de Parkinson et le complexe de capture neuronal de la dopamine |
| 001701 |
P. Horellou [France] ; E. Vigne ; M.-N. Castel ; P. Barneoud ; M. Perricaudet ; P. Delaere ; J. Mallet | Transplantation of cells genetically modified and direct intracerebral gene transfer with an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease |
| 001714 |
R.-M. Marie ; L. Barre [France] ; P. Rioux ; P. Allain [France] ; B. Lechevalier ; J.-C. Baron | PET imaging of neocortical monoaminergic terminals in Parkinson's disease |
| 001742 |
B. Naudin [France] ; J.-J. Bonnet ; J. Costentin | Acute L-DOPA pretreatment potentiates 6-hydroxydopamine-induced toxic effects on nigro-striatal dopamine neurons in mice |
| 001750 |
| Enzymes de protection contre les radicaux libres dans le système nerveux central de l'homme ― avec une référence particulière pour le mécanisme de la mort des neurones dopaminergiques dans la maladie de Parkinson |
| 001753 |
| Effets neurotoxiques induits par des radicaux libres sur le système dopaminergique nigro-striatal. Etude d'agents protecteurs |
| 001784 |
P. Gaspar [France] ; N. B. Jelloun ; A. Febvret | Sparing of the dopaminergic neurons containing calbindin-D28k and of the dopaminergic mesocortical projections in weaver mutant mice |
| 001787 |
A. Boireau [France] ; P. Dubedat ; F. Bordier ; C. Peny ; J.-M. Miquet ; G. Durand ; M. Meunier ; A. Doble | Riluzole and experimental parkinsonism : antagonism of MPTP-induced decrease in central dopamine levels in mice |
| 001794 |
S. Lehericy [France] ; J.-P. Brandel [France] ; E. C. Hirsch [France] ; P. Anglade [France] ; J. Villares [France] ; D. Scherman [France] ; C. Duyckaerts [France] ; F. Javoy-Agid [France] ; Yves Agid [France] | Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography |
| 001800 |
G. Boka [France] ; P. Anglade [France] ; D. Wallach ; F. Javoy-Agid [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease |
| 001805 |
A. Mouatt-Prigent [France] ; Yves Agid [France] ; E. C. Hirsch | Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease ? |
| 001808 |
A. Kastner [France] ; M. T. Herrero [France] ; E. C. Hirsch [France] ; J. Guillen ; M. R. Luquin ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France] | Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys : effect of levodopa and GM1 ganglioside therpay |
| 001811 |
M. Varastet [France] ; D. Riche [France] ; M. Maziere [France] ; P. Hantraye [France] | Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease |
| 001817 |
| Etude des transplants de neurones dopaminergiques embryonnaires dans le striatum de rat adulte. Approche multidisciplinaire: immunocytochimique, biochimique et comportementale |
| 001856 |
A. Kastner [France] ; E. C. Hirsch ; Yves Agid [France] ; F. Javoy-Agid | Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease |
| 001859 |
I. Marey-Semper [France] ; M. Gelman ; M. Levi-Strauss | The high sensitivity to rotenone of striatal dopamine uptake suggests the existence of a constitutive metabolic deficiency in dopaminergic neurons from the substantia nigra |
| 001861 |
P. Hantraye [France] ; M. Varastet [France] ; M. Peschanski [France] ; D. Riche [France] ; P. Cesaro ; J. C. Willer ; M. Maziere [France] | Stable Parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons |
| 001877 |
P. Damier [France] ; E. C. Hirsch ; P. Zhang ; Yves Agid [France] ; F. Javoy-Agid | Glutathione peroxidase, glial cells and Parkinson's disease |
| 001879 |
M. T. Herrero [France] ; I. Perez-Otano ; C. Oset ; A. Kastner [France] ; E. C. Hirsch [France] ; Yves Agid [France] ; M. R. Luquin ; J. A. Obeso ; J. Del Rio | GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys |
| 001887 |
E. C. Hirsch [France] | Does oxidative stress participate in nerve cell death in Parkinson's disease ? |
| 001890 |
M. T. Herrero [France] ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France] | Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum |
| 001945 |
P. P. Michel [France] ; S. Vyas ; Yves Agid [France] | Toxic effects of iron for cultured mesencephalic dopaminergic neurons derived from rat embryonic brains |
| 001947 |
P. P. Michel [France] ; Yves Agid [France] | The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures |
| 001953 |
A. Benazzouz [France] ; C. Gross ; J. Dupont [France] ; B. Bioulac | MPTP induced hemiparkinsonism in monkeys : behavioral, mechanographic, electromyographic and immunohistochemical studies |
| 001954 |
A. Kastner [France] ; E. C. Hirsch ; O. Lejeune ; F. Javoy-Agid ; O. Rascol [France] ; Yves Agid [France] | Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content ? |
| 001983 |
J.-M. Warter [France] ; C. Tranchant ; B. Lannes | Les greffes de cellules dopaminergiques autologues et hétérologues : une nouvelle possibilité de traitement de la maladie de Parkinson? |
| 001A49 |
S. Dumas ; F. Javoy-Agid ; E. Hirsch ; Yves Agid [France] ; J. Mallet | Tyrosine hydroxylase gene expression in human ventral mesencephalon : detection of tyrosine hydroxylase messenger RNA in neurites |
| 001A57 |
F. Javoy-Agid ; E. C. Hirsch ; S. Dumas ; C. Duyckaerts ; J. Mallet ; Yves Agid [France] | Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease : an in situ hybridization study |
| 001A93 |
D. Scherman ; C. Desnos ; F. Darchen ; P. Pollak ; F. Javoy-Agid ; Yves Agid [France] | Striatal dopamine deficiency in Parkinson's disease: role of aging |
| 001B26 |
E. Hirsch ; A. M. Graybiel ; Y. A. Agid | Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease |
